BlackRock
COYA icon

BlackRock’s Coya Therapeutics COYA Stock Holding History

BlackRock’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$599K Buy
102,408
+19,639
+24% +$91K ﹤0.01% 4521
2026
Q1 		$326K Buy
82,769
+3,623
+5% +$16.9K ﹤0.01% 4630
2025
Q4 		$459K Buy
79,146
+9,188
+13% +$55.9K ﹤0.01% 4503
2025
Q3 		$399K Buy
69,958
+1,702
+2% +$10.4K ﹤0.01% 4518
2025
Q2 		$392K Sell
68,256
-15,539
-19% -$90K ﹤0.01% 4504
2025
Q1 		$542K Buy
83,795
+7,602
+10% +$48.1K ﹤0.01% 4377
2024
Q4 		$437K Buy
76,193
+10,367
+16% +$70.6K ﹤0.01% 4443
2024
Q3 		$425K Buy
65,826
+1,248
+2% +$7.87K ﹤0.01% 4370
2024
Q2 		$391K Buy
64,578
+10,581
+20% +$85K ﹤0.01% 4406
2024
Q1 		$536K Buy
53,997
+32,222
+148% +$252K ﹤0.01% 4357
2023
Q4 		$161K Sell
21,775
-244
-1% -$1.35K ﹤0.01% 4692
2023
Q3 		$84.6K Buy
22,019
+14,586
+196% +$58K ﹤0.01% 4895
2023
Q2 		$30.3K Sell
7,433
-294
-4% -$1.36K ﹤0.01% 5150
2023
Q1 		$30.7K Buy
+7,727
New +$33.8K ﹤0.01% 5194

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

BlackRock's COYA Position: Q2 2026 in Review

BlackRock increased its Coya Therapeutics (COYA) stake by 24% in Q2 2026, buying an estimated $91K and bringing the position to 102,408 shares worth $599K. The position accounts for ﹤0.01% of the portfolio, ranked #4521.

BlackRock first reported a position in COYA in Q1 2023 and has held it in 14 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • BlackRock held 102,408 shares of Coya Therapeutics worth $599K as of Q2 2026.
  • BlackRock bought 19,639 Coya Therapeutics shares in Q2 2026, an estimated $91K.
  • Coya Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4521 holding.
  • BlackRock first reported a position in Coya Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.